Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
Retinal microvascular alterations and glymphatic dysfunction mediate the association between APOE ε4 and cognitive decline in Alzheimer's disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kwapong William Robert, Wen Caiyun, Wang Youjie, Hu Suqing, Hu Yihan, Wu Surui, Zheng Chunwen, Bonaventure Ip Yiu Ming, Wang Meihao, Wang Zhen
Аннотация
BACKGROUND: Vascular and glymphatic dysfunction are increasingly implicated in Alzheimer's disease (AD), particularly among apolipoprotein E (APOE) ε4 carriers. We investigated relationships among retinal microvasculature, glymphatic markers, and AD pathology.
METHODS: Seventy-six AD participants underwent retinal imaging, magnetic resonance imaging, and plasma biomarker assessment. Retinal fractal dimension (FD) and tortuosity (T), diffusion tensor imaging along the perivascular space (DTI-ALPS), periventricular diffusivity (PVeD), and small vessel disease (SVD) markers were analyzed.
RESULTS: APOE ε4 carriers showed reduced FD, increased T, and lower PVeD. Sparser microvasculature was associated with impaired glymphatic markers, greater vascular burden, abnormal plasma biomarkers, and worse cognition. Mediation analyses indicated that retinal FD and PVeD partially mediated the relationship between APOE ε4 and cognitive performance.
DISCUSSION: Retinal microvascular alterations reflect vascular-glymphatic dysfunction and may serve as non-invasive biomarkers linking genetic risk to cognitive decline in AD.
METHODS: Seventy-six AD participants underwent retinal imaging, magnetic resonance imaging, and plasma biomarker assessment. Retinal fractal dimension (FD) and tortuosity (T), diffusion tensor imaging along the perivascular space (DTI-ALPS), periventricular diffusivity (PVeD), and small vessel disease (SVD) markers were analyzed.
RESULTS: APOE ε4 carriers showed reduced FD, increased T, and lower PVeD. Sparser microvasculature was associated with impaired glymphatic markers, greater vascular burden, abnormal plasma biomarkers, and worse cognition. Mediation analyses indicated that retinal FD and PVeD partially mediated the relationship between APOE ε4 and cognitive performance.
DISCUSSION: Retinal microvascular alterations reflect vascular-glymphatic dysfunction and may serve as non-invasive biomarkers linking genetic risk to cognitive decline in AD.